Leica Biosystems was founded in 1989, and became a part of Danaher Corporation in 2006. Since then, it has continued to invest in product development.
Leica Biosystems is a global leader in developing solutions that help researchers and pathology laboratories shorten the time required to carry out all the procedures between biopsy and diagnosis. Company offers an extensive product range for each step in the pathology process - from sample preparation and staining to imaging and result analysis. The company’s goal is to make it possible to establish a diagnosis within 24 hours after biopsy.